Abstract
To investigate the diagnostic level of cystatin C and growth arrest-specific gene 6 (Gas6) levels in elderly type 2 diabetic patients with different degrees of diabetic nephropathy (DN). Four hundred and eighty-two old people, including 130 healthy controls, 130 normoalbuminuric diabetic patients, 122 with microalbuminuria, and 100 with macroalbuminuria, were recruited. Plasma Gas6 and serum cystatin C levels were measured. Plasma Gas6 concentration was significantly lower in diabetic patients with microalbuminuria or macroalbuminuria, as compared with diabetic subjects with normoalbuminuria; while cystatin C was significantly higher. Gas6 was inversely correlated with BMI, WHR, and HbA1c, while cystatin C was inversely correlated with urea nitrogen and creatinine. Multivariate logistic regression analysis showed that, after adjusted for established diabetes risk factors, higher plasma Gas6 was significantly associated with a decreased risk of DN, while higher serum cystatin C was significantly associated with an increased risk. Receiver operating characteristic curve analysis showed that Gas6 was better than cystatin C as a biomarker for early diagnosis and detection of DN, with a cutoff value of 9.435 ng/mL (86.1% sensitivity...Continue Reading
References
Jun 10, 1993·The New England Journal of Medicine·D M Nathan
Sep 12, 1997·The Journal of Biological Chemistry·P McCloskeyE T Liu
Nov 14, 1997·Diabetes Care·X R PanJ Liu
Apr 18, 1998·The Journal of Biological Chemistry·Y W FridellE T Liu
Aug 28, 2001·Diabetes Care·B P TabaeiW H Herman
Dec 14, 2001·Nature·P ZimmetJ Shaw
Mar 20, 2003·The Journal of Biological Chemistry·Kojiro NagaiToshio Doi
Jul 25, 2003·Diabetologia·D GuUNKNOWN InterASIA Collaborative Group
Oct 18, 2003·Metabolism: Clinical and Experimental·Caroline PerlemoineHenri Gin
Mar 17, 2004·Journal of Diabetes and Its Complications·Adam GordoisAlan Oglesby
Jul 15, 2005·Kidney International·Kojiro NagaiHidenori Arai
Feb 16, 2007·Journal of the American Society of Nephrology : JASN·Sanju A VargheseJohn M Arthur
Jul 20, 2007·Clinical Chemistry·Hassan DihaziFrank Strutz
Aug 25, 2007·Clinical Chemistry·Sylvain ClauserDelphine Borgel
May 23, 2008·Diabetes Research and Clinical Practice·Dongsheng HuUNKNOWN MS for the InterASIA Collaborative Group
Oct 22, 2008·Diabetes Research and Clinical Practice·G JerumsR J MacIsaac
Apr 25, 2009·Annals of Clinical Biochemistry·Edmund J LambPaul E Stevens
Mar 26, 2010·The New England Journal of Medicine·Wenying YangUNKNOWN China National Diabetes and Metabolic Disorders Study Group
May 28, 2010·Diabetes Care·Yi-Jen HungYi-Shing Shieh
Jun 23, 2011·JAMA : the Journal of the American Medical Association·Ian H de BoerJonathan Himmelfarb
Jan 31, 2013·Journal of the American Society of Nephrology : JASN·Maryam AfkarianIan H de Boer
Sep 5, 2013·JAMA : the Journal of the American Medical Association·Yu XuUNKNOWN 2010 China Noncommunicable Disease Surveillance Group
Feb 12, 2014·Renal Failure·Aybala Erek-ToprakFikriye Uras
Dec 10, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Yi-Jen HungChang-Hsun Hsieh
Citations
Nov 28, 2017·The Tohoku Journal of Experimental Medicine·Li-Chun YehXiao-Lun Lee
Jul 31, 2019·Disease Markers·Philip L Cohen, Wen-Hai Shao
Jul 2, 2017·Biotechnology Letters·Yanxin XiaoJun Wang
Apr 3, 2019·International Journal of Molecular Sciences·Ciprian N SilaghiAlexandra M Crăciun
Sep 6, 2019·Disease Markers·Livia SalmiLuigi Mario Castello
Nov 19, 2021·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Sopida Thipsawat